Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Shore

Showing results (81-90 of 587) with videos related to

Pageof 59
Sort By:
The Journal of Urology|February 6, 2026
Reply by AuthorsNeal D Shore, Stephen J Freedland
Future Oncology (London, England)|March 27, 2025
Enzalutamide in biochemically recurrent prostate cancer: key findings from the EMBARK studyNeal D Shore, Henry H Woo
Future Oncology (London, England)|March 25, 2025
Enzalutamide in biochemically recurrent prostate cancer: design and rationale of the EMBARK studyNeal D Shore, Henry H Woo
Journal of Cardiothoracic and Vascular Anesthesia|September 24, 2013
Pro: LVAD: patient's desire for termination of VAD therapy should be challengedRohinton J Morris, Elizabeth D Shore
Reviews in Urology|October 6, 2018
Member Census Shows LUGPA Practices Exhibit High Level of Innovation, Sophistication, and GrowthScott B Sellinger, Neal D Shore
Translational Andrology and Urology|April 14, 2025
Historic progression of prostatectomy techniques and associated outcomesLauren Folgosa Cooley, Neal D Shore
The Journal of Biological Chemistry|April 25, 1979
Spectral evidence for tyrosine ionization linked to a conformational change in liver alcohol dehydrogenase ternary complexesW R Laws, J D Shore
Biochemical and Biophysical Research Communications|July 13, 1970
The limiting rate of chelation of liver alcohol dehydrogenaseM J Gilleland, J D Shore
Genetics|December 1, 1995
Molecular and genetic analysis of the toxic effect of RAP1 overexpression in yeastK Freeman, M Gwadz, D Shore
The Journal of Biological Chemistry|November 10, 1981
Binding of high affinity heparin to antithrombin III. Characterization of the protein fluorescence enhancementS T Olson, J D Shore
Pageof 59

Showing results (81-90 of 587) with videos related to

Sort By:
Pageof 59
The Journal of Urology|February 6, 2026
Reply by AuthorsNeal D Shore, Stephen J Freedland
Future Oncology (London, England)|March 27, 2025
Enzalutamide in biochemically recurrent prostate cancer: key findings from the EMBARK studyNeal D Shore, Henry H Woo
Future Oncology (London, England)|March 25, 2025
Enzalutamide in biochemically recurrent prostate cancer: design and rationale of the EMBARK studyNeal D Shore, Henry H Woo
Journal of Cardiothoracic and Vascular Anesthesia|September 24, 2013
Pro: LVAD: patient's desire for termination of VAD therapy should be challengedRohinton J Morris, Elizabeth D Shore
Reviews in Urology|October 6, 2018
Member Census Shows LUGPA Practices Exhibit High Level of Innovation, Sophistication, and GrowthScott B Sellinger, Neal D Shore
Translational Andrology and Urology|April 14, 2025
Historic progression of prostatectomy techniques and associated outcomesLauren Folgosa Cooley, Neal D Shore
The Journal of Biological Chemistry|April 25, 1979
Spectral evidence for tyrosine ionization linked to a conformational change in liver alcohol dehydrogenase ternary complexesW R Laws, J D Shore
Biochemical and Biophysical Research Communications|July 13, 1970
The limiting rate of chelation of liver alcohol dehydrogenaseM J Gilleland, J D Shore
Genetics|December 1, 1995
Molecular and genetic analysis of the toxic effect of RAP1 overexpression in yeastK Freeman, M Gwadz, D Shore
The Journal of Biological Chemistry|November 10, 1981
Binding of high affinity heparin to antithrombin III. Characterization of the protein fluorescence enhancementS T Olson, J D Shore
Pageof 59